awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39696831-BBF8D1AA-9146-4873-A2D9-CA094D627283
Q39696831-BBF8D1AA-9146-4873-A2D9-CA094D627283
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39696831-BBF8D1AA-9146-4873-A2D9-CA094D627283
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir.
P2860
Q39696831-BBF8D1AA-9146-4873-A2D9-CA094D627283
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39696831-BBF8D1AA-9146-4873-A2D9-CA094D627283
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32fa9aeab7a3897bd7e2e9758c991180911562b6
P2860
Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.